Atlas Trials

Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy

Clinical trial NCT02605525 · WITHDRAWN

Trial details

NCT number
NCT02605525
Sponsor
Baxalta now part of Shire
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immunoglobulin A Nephropathy
Start date
2015-12-31
Primary completion
2016-11-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.